On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Liver Disease Diagnosis and Treatment

TopicLeading institutions, researchers & key papers

Liver Disease Diagnosis and Treatment is a topic indexed in ScholarIQ from OpenAlex.

What is known about Liver Disease Diagnosis and Treatment?

ScholarIQrecord summary

This cluster of papers focuses on the epidemiology, diagnosis, management, and pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD). It covers topics such as liver fibrosis, insulin resistance, hepatic steatosis, metabolic syndrome, nonalcoholic steatohepatitis (NASH), and non-invasive assessment methods. The papers also discuss the association of NAFLD with hepatocellular carcinoma and its impact on public health.

How many works does Liver Disease Diagnosis and Treatment have?

ScholarIQindexed works

Liver Disease Diagnosis and Treatment has 1,191 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Liver Disease Diagnosis and Treatment?

ScholarIQopenalex

The OpenAlex for Liver Disease Diagnosis and Treatment is on the source record.

What are the most-cited papers on Liver Disease Diagnosis and Treatment?

ScholarIQmost cited works
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair M. Younossi, Quentin M. Anstee, M. Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi
Nature Reviews Gastroenterology & Hepatology. 20175,300 CitationsOPEN ACCESS
Use and Abuse of HOMA Modeling
T. M. Wallace, J Lévy, David R. Matthews
Diabetes Care. 20045,146 CitationsOPEN ACCESS
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam, Philip N. Newsome, Shiv Kumar Sarin, Quentin M. Anstee, Giovanni Targher, Manuel Romero‐Gómez, Shira Zelber‐Sagi, Vincent Wai‐Sun Wong, Jean‐François Dufour, Jörn M. Schattenberg, Takumi Kawaguchi, Marco Arrese, Luca Valenti, Gamal Shiha, Claudio Tiribelli, Hannele Yki‐Järvinen, Jian-Gao Fan, Henning Grønbæk, Yusuf Yılmaz, Helena Cortez‐Pinto, Cláudia P. Oliveira, Pierre Bédossa, Leon A. Adams, Ming‐Hua Zheng, Yasser Fouad, Wah‐Kheong Chan, Nahúm Méndez‐Sánchez, Sang Hoon Ahn, Laurent Castéra, Elisabetta Bugianesi, Vlad Ratziu, Jacob George
Journal of Hepatology. 20204,467 CitationsOPEN ACCESS
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Mohammed Eslam, Arun J. Sanyal, Jacob George, Arun J. Sanyal, Brent A. Neuschwander‐Tetri, Claudio Tiribelli, David E. Kleiner, Elizabeth M. Brunt, Elisabetta Bugianesi, Hannele Yki‐Järvinen, Henning Grønbæk, Helena Cortez‐Pinto, Jacob George, Jian‐Gao Fan, Luca Valenti, Manal F. Abdelmalek, Manuel Romero‐Gómez, Mary E. Rinella, Marco Arrese, Mohammed Eslam, Pierre Bédossa, Philip N. Newsome, Quentin M. Anstee, Rajiv Jalan, Ramón Bataller, Rohit Loomba, Silvia Sookoian, Shiv Kumar Sarin, Stephen A. Harrison, Takumi Kawaguchi, Vincent Wai‐Sun Wong, Vlad Ratziu, Yusuf Yılmaz, Zobair M. Younossi
Gastroenterology. 20203,322 CitationsOPEN ACCESS
NAFLD: A multisystem disease
Christopher D. Byrne, Giovanni Targher
Journal of Hepatology. 20153,122 CitationsOPEN ACCESS

Where is Liver Disease Diagnosis and Treatment research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Liver Disease Diagnosis and Treatment is open access?

ScholarIQopen access share
87%OPEN ACCESS
Gold
0%
Green
33%
Hybrid
20%
Bronze
33%
Closed
13%

Related on ScholarIQ

470M+ articles · 14-day free trial